Cargando…
Pilot assessment of vascular endothelial growth factor receptors and trafficking pathways in recurrent and metastatic canine subcutaneous mast cell tumours
Canine subcutaneous mast cell tumour (scMCT) shows less aggressive biological behaviour than cutaneous MCT. Vascular endothelial growth factor receptor 2 (VEGFR2) is expressed by neoplastic cells in canine scMCT, but the relevance of this signalling pathway for disease pathobiology is not clear. The...
Autores principales: | Da Silva, Lucas, Fonseca‐Alves, Carlos E., Thompson, Jennifer J., Foster, Robert A., Wood, Geoffrey A., Amorim, Renee L., Coomber, Brenda L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645839/ https://www.ncbi.nlm.nih.gov/pubmed/29067211 http://dx.doi.org/10.1002/vms3.66 |
Ejemplares similares
-
Beclin-1 is a novel predictive biomarker for canine cutaneous and
subcutaneous mast cell tumors
por: Knight, Britta J., et al.
Publicado: (2021) -
Prognostic value of epigenetic markers for canine mast cell cancer
por: Syed, Shahzar, et al.
Publicado: (2023) -
Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors
por: de Nardi, Andrigo Barboza, et al.
Publicado: (2022) -
Mutations in C-KIT exon 11 in canine cutaneous mast cell tumors
por: Neto, Rafael T, et al.
Publicado: (2013) -
Intercellular interactions between mast cells and stromal fibroblasts obtained from canine cutaneous mast cell tumours
por: Pulz, Lidia H., et al.
Publicado: (2021)